Wolverine Trading, LLC Siga Technologies Inc Call Options Transaction History

Wolverine Trading, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$4.51 - $8.92 $10,373 - $20,516	-2,300 Reduced 18.25%	10,300 $88,000
Q4 2023 Feb 14, 2024	SELL	$4.82 - $6.25 $7,230 - $9,375	-1,500 Reduced 10.64%	12,600 $70,000
Q3 2023 Nov 15, 2023	BUY	$4.32 - $5.77 $17,712 - $23,657	4,100 Added 41.0%	14,100 $74,000
Q2 2023 Aug 23, 2023	SELL	$5.0 - $6.31 $22,500 - $28,395	-4,500 Reduced 31.03%	10,000 $50,000
Q1 2023 May 15, 2023	SELL	$5.23 - $8.42 $84,203 - $135,562	-16,100 Reduced 52.61%	14,500 $81,000

Q4 2022 Feb 14, 2023	BUY	$7.29 - $10.14 $223,074 - $310,284	30,600 New	30,600 $225,000
Q2 2022 Aug 15, 2022	BUY	$6.5 - $13.68 $276,250 - $581,400	42,500 New	42,500 $474,000

156

33.6M

314K

329K

Ticker SIGA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 73,024,096
Market Cap $565M
Description
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.